Cargando…
A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models
Parkinson’s disease (PD) is a progressive neurodegenerative motor disorder without an available therapeutic to halt the formation of Lewy bodies for preventing dopaminergic neuronal loss in the nigrostriatal pathway. Since oxidative-stress-mediated damage has been commonly reported as one of the mai...
Autores principales: | Ghosh, Anurupa A., Verma, Dinesh Kumar, Cabrera, Gabriela, Ofori, Kwadwo, Hernandez-Quijada, Karina, Kim, Jae-Kwan, Chung, Joo Hee, Moore, Michael, Moon, Sung Hwan, Seo, Jong Bok, Kim, Yong-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030373/ https://www.ncbi.nlm.nih.gov/pubmed/35457082 http://dx.doi.org/10.3390/ijms23084262 |
Ejemplares similares
-
A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice
por: Ofori, Kwadwo, et al.
Publicado: (2023) -
Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson’s Disease Models
por: Verma, Dinesh Kumar, et al.
Publicado: (2021) -
The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson’s Disease Models
por: Verma, Dinesh Kumar, et al.
Publicado: (2020) -
The Role of NOX4 in Parkinson’s Disease with Dementia
por: Choi, Dong-Hee, et al.
Publicado: (2019) -
The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice
por: Cui, Yu, et al.
Publicado: (2018)